Influence of prolonged treatment with omalizumab on the development of solid epithelial cancer in patients with atopic asthma and chronic idiopathic urticaria: A systematic review and meta-analysis.

Amy JohnstonChristine SmithCarine ZhengShawn D AaronShannon E KellyBecky SkidmoreGeorge A Wells

Published in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2019)

There is insufficient evidence to determine whether long-term treatment with omalizumab influences development or progression of solid epithelial cancer in these patient populations. PROSPERO registration # CRD 42018082211.

Keyphrases

papillary thyroid
squamous cell
chronic obstructive pulmonary disease
squamous cell carcinoma
air pollution
drug induced
atopic dermatitis